BioViva USA
PrivateLast Round
Series A
Nov 11, 2022
Total Funding Raised
$250,000
Company Overview
BioViva USA operates in Healthcare & Life Sciences and is based in Bainbridge Island, Washington. Its latest recorded funding round was an Early Funding round in April 2016.
BioViva USA is a biotechnology company that develops gene therapy platforms to treat severe genetic disorders and address the root causes of cellular aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioViva USA Comparables
Compare BioViva USA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlimited Bio | 79% | |
| YouthBio Therapeutics | 78% | |
| Turn Biotechnologies | 77% |
For institutional investors. Book with your work email.
BioViva USA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2022 | ||||
| Early Funding | Apr 1, 2016 | ||||
| Seed | May 27, 2015 |
For institutional investors. Book with your work email.
BioViva USA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Knowledge Life Sciences | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2016
Raised funding with participation from Deep Knowledge Life Sciences.
- May 27, 2015
$250K raised in Seed round.
For institutional investors. Book with your work email.
BioViva USA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioViva USA's valuation, stock price, and market status.
Is BioViva USA a public or private company?
BioViva USA is a private company.
What is the current stock price of BioViva USA?
BioViva USA is a private company, so its shares have no public market price. Caplight tracks BioViva USA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioViva USA worth (valuation)?
Valuation information for BioViva USA is not publicly available.
Can I buy BioViva USA stock?
BioViva USA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioViva USA's last funding round?
BioViva USA's most recent funding round was Series A on November 11, 2022.
Who are the main investors in BioViva USA?
Key investors in BioViva USA include Deep Knowledge Life Sciences.
Will BioViva USA IPO soon?
No public IPO plans have been announced for BioViva USA.
How can I track BioViva USA secondary market activity?
Caplight tracks bids, offers, and trades in BioViva USA's shares on secondary markets.